p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 401–500 of 1,000
Li, T., Liu, X., Jiang, L., Manfredi, J., Zha, S., & Gu, W. (2016) · Oncotarget · doi:10.18632/oncotarget.7864 · Cited by 85
“Interestingly, the whole body X-ray analysis showed that p533KR/3KRXrcc4-/- mice displayed kyphosis (also known as hunchback), an abnormal curvature of the spine, at the age of 22 weeks (Figures 3E and 3F), one of the main premature aging associated phenotypes that were previously reported in p53 mutant mice [33, 34].”
BackgroundLu, J. Y., Simon, M., Zhao, Y., Ablaeva, J., Corson, N., Choi, Y., Yamada, K. Y. H., Schork, N. J., Hood, W. R., Hill, G. E., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.011 · Cited by 84
Tumor suppression by p53: making cells senescent.
Qian, Y., & Chen, X. (2010) · PubMed · doi:10.14670/hh-25.515 · Cited by 85
“Similar early-aging associated phenotypes were observed in mice with a deletion mutation of the first six exons in the p53 gene (Tyner et al., 2002).”
Wilder, P. T., Lin, J., Bair, C. L., Charpentier, T. H., Yang, D., Liriano, M. A., Varney, K. M., Lee, A., Oppenheim, A. B., Adhya, S. L., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.024 · Cited by 85
“On the other hand, if p53 levels are too high, then phenotypes associated with aging and problems with skin and bone occur [37].”
BackgroundDo tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence?
Pelicci, P. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420750 · Cited by 85
Solozobova, V., & Blattner, C. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.202 · Cited by 98
Probing p53 biological functions through the use of genetically engineered mouse models
Attardi, L. D., & Donehower, L. A. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.022 · Cited by 98
Self-citationPINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis
Lee, S.-Y., An, H., Kim, J. M., Sung, M.-J., Kim, H. K., Kim, H. K., Oh, J., Jeong, H. Y., Lee, Y. H., Yang, T., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02656-4 · Cited by 90
“Mouse models of premature aging present signs of oxidative damage and osteoporotic features [57, 58].”
BackgroundAbbate, E., & Sagri, M. (2011) · Quaternary International · doi:10.1016/j.quaint.2011.02.043 · Cited by 100
Cellular senescence and DNA repair
Lou, Z., & Chen, J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.009 · Cited by 95
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 84
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53
Salvioli, S., Capri, M., Bucci, L., Lanni, C., Racchi, M., Uberti, D. L., Memo, M., Mari, D., Govoni, S. M., & Franceschi, C. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0639-6 · Cited by 100
“[50] and discussed above, in which a truncated form of p53 is expressed together with a wt one.”
BackgroundMutation Screening of the TP53 Gene by Temporal Temperature Gel Electrophoresis (TTGE)
Sørlie, T., Johnsen, H., Vu, P., Lind, G. E., Lothe, R. A., & Børresen‐Dale, A. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-739-6_25 · Cited by 86
Pant, V., Xiong, S., Jackson, J. G., Post, S. M., Abbas, H. A., Quintás-Cardama, A., Hamir, A. N., & Lozano, G. (2013) · Genes & Development · doi:10.1101/gad.227249.113 · Cited by 84
“Increase in p53 activity is also linked with increased genomic aberrations, stem cell depletion, and aging phenotypes (Tyner et al. 2002; Liu et al. 2010).”
BackgroundCellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential
He, Y., Xie, W., Li, H., Jin, H., Zhang, Y., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.793088 · Cited by 95
“Of note, mouse models with constitutively active p53 alleles imply that increased p53 activity results in ageing phenotypes (Tyner et al., 2002).”
BackgroundTherapeutic targeting of p53 by small molecules
Selivanova, G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.006 · Cited by 93
Unraveling the role of FoxOs in bone—Insights from mouse models
Almeida, M. (2011) · Bone · doi:10.1016/j.bone.2011.05.023 · Cited by 81
“Conversely, both osteoblast numbers and bone formation are decreased in mice treated with an inhibitor of the antioxidant glutathione [18], and murine models of premature aging associated with oxidative damage exhibit osteoporosis [19, 20].”
BackgroundCell divisions and mammalian aging: integrative biology insights from genes that regulate longevity
de Magalhães, J. P., & Faragher, R. G. A. (2008) · BioEssays · doi:10.1002/bies.20760 · Cited by 81
“It has been proposed that the premature aging in p53þ/m mice is due to stem cells undergoing premature replicative senescence, which causes a premature exhaustion of their proliferative capacity and in turn a lack of organ homeostasis.((17)) This strain exemplifies some key trends observed in many mouse models of acce…”
BackgroundSkin aging: are adipocytes the next target?
Kruglikov, I. L., & Scherer, P. E. (2016) · Aging · doi:10.18632/aging.100999 · Cited by 96
“In addition, p53 mutant mice displaying an early agingassociated phenotype demonstrate depleted dWAT structures in 24-month-old animals (which can be considered as very old), whereas the wild type mice of the same age show significantly reduced but still present dWAT layers [36].”
Backgroundp53: link to the past, bridge to the future
Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.1362905 · Cited by 81
“…isoforms likely explains the fact that although three different mouse models with enhanced p53 activity have been generated (Garcia-Cao et al. 2002; Tyner et al. 2002; Maier et al. 2004) and these mice are not susceptible to spontaneous tumors (Garcia-Cao et al. 2002; Tyner et al. 2002), only two…”
BackgroundShort-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
“This appears to support the idea of a trade-off between aging and cancer (Kirkwood and Austad 2000; Tyner et al. 2002), although this view considers only the autonomous aspect of senescence (see “Nonautonomous Effectors” below), and telomere shortening is just one way to trigger senescence.”
BackgroundNapoli, M., & Flores, E. R. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.384 · Cited by 91
“1Department of Molecular Oncology, Cancer Biology and Evolution Program, Department of Cutaneous Oncology, H. Lee Moffitt”
BackgroundMühleder, S., Fernández-Chacón, M., García-Gónzalez, I., & Benedito, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03664-y · Cited by 89
The role of p53 in developmental syndromes
Bowen, M. E., & Attardi, L. D. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy087 · Cited by 86
Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets
Wu, L., Xie, X., Liang, T., Ma, J., Yang, L., Yang, J., Li, L., Xi, Y., Li, H., Zhang, J., et al. (2021) · Biomolecules · doi:10.3390/biom12010039 · Cited by 92
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 61
Antagonistic pleiotropy and p53
Ungewitter, E., & Scrable, H. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.06.002 · Cited by 79
“A phenotype of accelerated aging and reduced life span in mice was reported in 2002 in association with a mutant (‘‘m’’) allele of p53 that could enhance the ability of p53 to act as a tumor suppressor (Tyner et al., 2002).”
InfluentialThe Paradox of p53: What, How, and Why?
Aylon, Y., & Oren, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026328 · Cited by 79
“Notably, p53 pathway hyperactivation accelerates tissue deterioration and promotes the appearance of ageassociated pathologies in mice (Tyner et al. 2002; Maier et al. 2004).”
BackgroundInterleukin-1α Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer
Kumar, S., Kishimoto, H., Chua, H. L., Badve, S., Miller, K. D., Bigsby, R. M., & Nakshatri, H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63608-5 · Cited by 90
Genes, ageing and longevity in humans: Problems, advantages and perspectives
Salvioli, S., Olivieri, F., Marchegiani, F., Cardelli, M., Santoro, A., Bellavista, E., Mishto, M., Invidia, L., Capri, M., Valensin, S., et al. (2006) · Free Radical Research · doi:10.1080/10715760600917136 · Cited by 78
“[164] Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA.”
Accelerating aging by mouse reverse genetics: a rational approach to understanding longevity
Hasty, P., & Vijg, J. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00082.x · Cited by 78
“For the first mouse model, p53 is activated by an N-terminal deletion that probably produces a dominant protein (Tyner et al., 2002).”
BackgroundCalorie restriction and the nutrient sensing signaling pathways
Dilova, I., Easlon, E. J., & Lin, S.-J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6381-y · Cited by 85
da Luz, P. L., Tanaka, L. Y., Brum, P. C., Dourado, P. M. M., Favarato, D., Krieger, J. E., & Laurindo, F. R. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.007 · Cited by 84
Wang, D., Haile, A., & Jones, L. (2013) · Bone · doi:10.1016/j.bone.2013.01.009 · Cited by 76
Chen, J.-R., Lazarenko, O. P., Haley, R. L., Blackburn, M. L., Badger, T. M., & Ronis, M. J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081011 · Cited by 77
“Previous reports have strikingly shown that an activating mutation of p53 causes early onset of aging-associated phenotypes in mice.((36)) Our above data showed that EtOH induces p53 and p21 in bone.”
BackgroundIs cellular senescence an example of antagonistic pleiotropy?
Giaimo, S., & d’Adda di Fagagna, F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00807.x · Cited by 77
Reduced expression of the Caenorhabditis elegans p53 ortholog cep-1 results in increased longevity
Arum, O., & Johnson, T. E. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.9.951 · Cited by 64
“Quite intriguingly, CEP-1 overexpression leads to widespread caspaseindependent cell death, which is lethal to the organism at any stage of life (8), as p53 overexpression leads to embryonic lethality in Mus musculus (2).”
BackgroundCau, P., Navarro, C. L., Harhouri, K., Roll, P., Sigaudy, S., Kaspi, É., Perrin, S., Sandre‐Giovannoli, A. D., & Lévy, N. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.021 · Cited by 87
“shown to be affected such as mitochondrial or TP53 [146,147].”
BackgroundCavati, G., Pirrotta, F., Merlotti, D., Ceccarelli, E., Calabrese, M., Gennari, L., & Mingiano, C. (2023) · Antioxidants · doi:10.3390/antiox12040928 · Cited by 95
Refaey, M. E., Watkins, C. P., Kennedy, E. J., Chang, A., Zhong, Q., Ding, K., Shi, X., Xu, J., Bollag, W. B., Hill, W., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.034 · Cited by 81
Aging increases CCN1 expression leading to muscle senescence
Du, J., Klein, J. D., Hassounah, F., Zhang, J., Zhang, C., & Wang, X. H. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00066.2013 · Cited by 76
“with mutations that produce a constitutively active p53 display early aging-associated phenotypes (41).”
BackgroundSoerensen, M., Dato, S., Tan, Q., Thinggaard, M., Kleindorp, R., Beekman, M., Jacobsen, R., Suchiman, H. E. D., de Craen, A. J. M., Westendorp, R. G. J., et al. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.02.010 · Cited by 76
“Studies using various animal models have found that either depletion or over-expression of some of these candidate genes affect the life span of the organism (e.g. GH, GPX1, FOXO, KL, GHRHR, POLB, RAD52, INS and TP53 (Bartke, 2005; Cabelof et al., 2006; Flurkey et al., 2001; Giannakou et al., 2004; Holzenberger et al.…”
BackgroundInfluentialDifferential expression of the liver proteome in senescence accelerated mice
Cho, Y., Bae, S., Choi, B., Cho, S. Y., Song, C., Yoo, J., & Paik, Y. (2003) · PROTEOMICS · doi:10.1002/pmic.200300562 · Cited by 82
Pekovic, V., & Hutchison, C. J. (2008) · Journal of Anatomy · doi:10.1111/j.1469-7580.2008.00928.x · Cited by 75
“Mouse models with high expression or activity of p53 have a shorter lifespan and show signs of premature ageing (Tyner et al. 2002; Maier et al. 2004) and over-expression of CDK inhibitor p16 in stem cells leads to premature exhaustion of their activity (Janzen et al.”
BackgroundRibozyme-Mediated Induction of Apoptosis in Human Cancer Cells by Targeted Repair of Mutant p53 RNA
Shin, K.-S., Sullenger, B. A., & Lee, S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.007 · Cited by 75
“In addition, it has been recently shown that mice engineered to have high p53 activity are resistant to tumors but age prematurely [29].”
BackgroundIwashina, T., Mochida, J., Sakai, D., Yamamoto, Y., Miyazaki, T., Ando, K., & Hotta, T. (2006) · Spine · doi:10.1097/01.brs.0000217687.36874.c4 · Cited by 75
“The link between SV40 T antigen and telomeres, which determine the lifespan of cells, is being studied, but a definite relation has not been established.(24,25) Studies that involve the transplantation of this cell line in immunodeficient animals, such as nude or SCID mice, are needed to examine cell differentiation a…”
Backgroundp53: guardian AND suppressor of longevity?
Donehower, L. A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.007 · Cited by 82
Self-citation30 years and a long way into p53 research
Hainaut, P. L., & Wiman, K. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70198-6 · Cited by 89
Mechanistic advances in osteoporosis and anti‐osteoporosis therapies
Wang, H., Luo, Y., Wang, H., Li, F., Yu, F., & Ye, L. (2023) · MedComm · doi:10.1002/mco2.244 · Cited by 88
Cockayne syndrome group B (CSB) protein: At the crossroads of transcriptional networks
Vélez-Cruz, R., & Egly, J. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.03.004 · Cited by 82
Lodygin, D., Menssen, A., & Hermeking, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16588 · Cited by 74
“Supporting this notion on the organismal level, mice that have been engineered to display elevated p53 activity show a decreased rate of tumor formation and premature aging (6).”
BackgroundDNA double-strand breaks: A potential causative factor for mammalian aging?
Li, H., Mitchell, J. R., & Hasty, P. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.002 · Cited by 83
Making ends meet in old age: DSB repair and aging
Gorbunova, V. A., & Seluanov, A. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.02.008 · Cited by 84
Ohtani, N., Imamura, Y., Yamakoshi, K., Hirota, F., Nakayama, R., Kubo, Y., Ishimaru, N., Takahashi, A., Hirao, A., Shimizu, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706949104 · Cited by 73
The evolution and expression of virulence
Ebert, D., & Bull, J. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0012 · Cited by 83
Osteoprotective Roles of Green Tea Catechins
Huang, H., Cheng, T., Lin, S., Ho, C.-J., Chyu, J., Yang, R., Chen, C., & Shen, C. (2020) · Antioxidants · doi:10.3390/antiox9111136 · Cited by 78
“Osteoporosis-related fragility fractures are noted in a murine model of premature aging and are characteristic of oxidative stress [35].”
BackgroundThe long and winding road of reprogramming-induced rejuvenation
Yücel, A. D., & Gladyshev, V. N. (2024) · Nature Communications · doi:10.1038/s41467-024-46020-5 · Cited by 91
“Augmentation of the p53 pathway in mice causes stem cells to enter senescence atanearliertimepoint,whichcouldpotentiallyrepresentasafetyissue for the in vivo 7c treatment 26 .”
BackgroundREGγ deficiency promotes premature aging via the casein kinase 1 pathway
Li, L., Zhao, D., Wei, H., Yao, L., Dang, Y., Amjad, A., Xu, J., Liu, J., Guo, L., Li, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308497110 · Cited by 72
“After 12 mo of age, REGγ mice gradually displayed signs of premature aging (2, 21, 22).”
BackgroundInfluentialSelf-citationBhattacharya, S., Chaum, E., Johnson, D. A., & Johnson, L. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10495 · Cited by 81
Replicative stress, stem cells and aging
Ruzankina, Y., Asare, A., & Brown, E. J. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.009 · Cited by 82
“In one mouse model, a putative 24kD N-terminally truncated form of p53 (p53 m ) was generated in the course of conventional gene targeting (Tyner et al., 2002).”
Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53
Medrano, S., Burns‐Cusato, M., Atienza, M., Rahimi, D., & Scrable, H. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.016 · Cited by 76
“Changes in the pattern of p53 isoform expression that cause constitutive activation of p53 are associated with a decreased risk of tumorigenesis and premature aging in genetically altered mice [39,65].”
BackgroundHarding, C., Pompei, F., Lee, E. E., & Wilson, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1670 · Cited by 73
“(36) and dietary restrictions, must be considered with both objectives in mind.”
BackgroundImpacts of transcriptional regulation on aging and senescence
Roy, A. K., Oh, T., Rivera, O., Mubiru, J., Song, C. S., & Chatterjee, B. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00006-5 · Cited by 72
Cdk2: a key regulator of the senescence control function of Myc
Hydbring, P., & Larsson, L. (2010) · Aging · doi:10.18632/aging.100140 · Cited by 81
“In support of this, telomerase-deficient mice as well as mice expressing an overactive mutant of p53 have a significantly shortened lifespan [43,44,45].”
BackgroundLiu, W., Qi, M., Konermann, A., Zhang, L., Jin, F., & Jin, Y. J. (2015) · Aging · doi:10.18632/aging.100728 · Cited by 72
p53: at the crossroad between cancer and ageing
Papazoglu, C., & Mills, A. (2007) · The Journal of Pathology · doi:10.1002/path.2086 · Cited by 72
“One caveat of this model is that the m allele was originally reported to have a deletion of unknown size upstream of the p53 gene [16].”
BackgroundInfluentialTranscriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence
Collin, G., Huna, A., Warnier, M., Flaman, J.-M., & Bernard, D. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0300-z · Cited by 71
Blasco, R., Rosell, J., Gopher, A., & Barkai, R. (2014) · Journal of Anthropological Archaeology · doi:10.1016/j.jaa.2014.06.005 · Cited by 69
The Dose Window for Radiation-Induced Protective Adaptive Responses
Mitchel, R. E. J. (2009) · Dose-Response · doi:10.2203/dose-response.09-039.mitchel · Cited by 70
“Conversely, mice that have been modified to have a constitutively activated Trp53 are nearly free of cancer risk (Tyner et al. 2002).”
BackgroundTime-dependent replicative senescence vs. disturbed flow-induced pre-mature aging in atherosclerosis
Dominic, A., Banerjee, P., Hamilton, D. J., Le, N., & Abe, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101614 · Cited by 77
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Zhang, J., Xu, E., Ren, C., Yan, W., Zhang, M., Chen, M., Cardiff, R. D., Imai, D. M., Wisner, E. R., & Chen, X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415607112 · Cited by 80
“Notably, similar to Rbm38 mice, both p53 and p44 mice express a hyperactive p53 and exhibit signs of premature aging (36, 37).”
Backgroundp53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells
He, Y., de Castro, L. F., Shin, M. H., Dubois, W., Yang, H. H., Jiang, S., Mishra, P. J., Ren, L., Gou, H., Lal, A., et al. (2014) · Stem Cells · doi:10.1002/stem.1925 · Cited by 73
Checkpoint Proteins Control Survival of the Postmitotic Cells in Caenorhabditis elegans
Olsen, A., Vantipalli, M. C., & Lithgow, G. J. (2006) · Science · doi:10.1126/science.1124981 · Cited by 70
Cancer Resistance in Transgenic Mice Expressing the SAC Module of Par-4
Zhao, Y., Burikhanov, R., Qiu, S. G., Lele, S. M., JENNINGS, C. D., Bondada, S., Spear, B. T., & Rangnekar, V. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2124 · Cited by 76
“Thus, aberrant expression of a transgene may inversely affect suppression of tumor growth and aging (27, 28).”
Ogawa, F., Sander, C. S., Hansel, A., Oehrl, W., Kasperczyk, H., Elsner, P. U., Shimizu, K., Heinemann, S. H., & Thiele, J. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700116 · Cited by 72
“, 2003) and may contribute to the short lifespan observed in the p53-overexpressed mouse (Tyner et al., 2002).”
BackgroundLongevity genes: from primitive organisms to humans
Warner, H. R. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.015 · Cited by 75
van Heemst, D., den Reijer, P. M., & Westendorp, R. G. J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.011 · Cited by 87
The non‐existent aging program: how does it work?
Bredesen, D. E. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00121.x · Cited by 69
Derry, W. B., Bierings, R., van Iersel, M., Satkunendran, T., Reinke, V., & Rothman, J. H. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402075 · Cited by 70
“elegans(30) and increased p53 activity has been associated with an increased rate of aging in flies and mice.(31,32) It will be”
BackgroundA FRT-flanked p53 mouse to generate primary tumors with Flp recombinase
Lee, C.-L., Moding, E. J., Huang, X., Li, Y., Woodlief, L. Z., Rodrigues, R. C., Ma, Y., & Kirsch, D. G. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.009084 · Cited by 69
“Interestingly, a mouse with deletion of the first six exons of p53 was previously reported to express a truncated RNA capable of coding for the C-terminus of the p53 protein that can be detected only after in vitro translation (Tyner et al., 2002).”
BackgroundResultInsulin-like growth factor-1 signaling in cardiac aging
Lee, W. S., & Kim, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.029 · Cited by 74
“Irreversible growth arrest is also triggered by the activation of oncogenes, such as Ras [49], and by the expression of activated tumor-suppressor genes [50,51].”
BackgroundThe Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging
Farr, J. N., & Almeida, M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3564 · Cited by 69
“Even further support comes fromgeneticmousemodels of premature aging((135,136)) or global deletion of antioxidant genes (eg, Sod1((137)) or Sod2((138))), which are characterized by elevated oxidative stress levels yet low bone mass.”
BackgroundBmi-1 Reduction Plays a Key Role in Physiological and Premature Aging of Primary Human Keratinocytes
Cordisco, S., Maurelli, R., Bondanza, S., Stefanini, M., Zambruno, G., Guerra, L., & Dellambra, E. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.355 · Cited by 73
“In addition, alteration of p53 activity in mouse models induces premature aging, suggesting the possible involvement of p53 in the regulation of the mammalian aging (Tyner et al., 2002; Dumble et al., 2007).”
BackgroundTimed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression
Hinkal, G., Parikh, N., & Donehower, L. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006654 · Cited by 68
Self-citationCancer and aging: Epidemiology and methodological challenges
Pedersen, J. K., Engholm, G., Skytthe, A., & Christensen, K. (2016) · Acta Oncologica · doi:10.3109/0284186x.2015.1114670 · Cited by 68
“This study showed that p53 mutant mice with augmented p53 activity displayed signs of early aging and, at the same time, an enhanced resistance to spontaneous tumors compared with wild types [4].”
ResultConnecting the Dots: From DNA Damage and Repair to Aging
Pan, M., Li, K., Lin, S., & Hung, W.-C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050685 · Cited by 80
The Ataxia Telangiectasia–Mutated Target Site Ser18 Is Required for p53-Mediated Tumor Suppression
Armata, H. L., Garlick, D. S., & Sluss, H. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1610 · Cited by 68
“Models expressing truncated p53 (33, 34) and engineered to produce extra p53 (39, 40) show protection from tumor burden.”
BackgroundDownregulation of APE1/Ref-1 Is Involved in the Senescence of Mesenchymal Stem Cells
Heo, J. Y., Jing, K., Song, K., Seo, K.-S., Park, J., Kim, J.-S., Jung, Y.-J., Hur, G.-M., Jo, D.-Y., Kweon, G.-R., et al. (2009) · Stem Cells · doi:10.1002/stem.54 · Cited by 74
Early Life Exposure to the 1918 Influenza Pandemic and Old-Age Mortality by Cause of Death
Myrskylä, M., Mehta, N. K., & Chang, V. W. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301060 · Cited by 67
“Indeed, increasing p53 levels may decrease cancer risk(56) but also accelerate other aging-related diseases.(52) Previous research documents that inflammation may influence the functioning of p53, but has not considered the role of early life exposures.”
BackgroundRETRACTED ARTICLE:Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice
Safdar, A., Khrapko, K., Flynn, J. M., Saleem, A., De Lisio, M., Johnston, A. P. W., Kratysberg, Y., Samjoo, I. A., Kitaoka, Y., Ogborn, D. I., et al. (2015) · Skeletal Muscle · doi:10.1186/s13395-016-0075-9 · Cited by 66
“It was unfeasible to generate PolG mice with over-expression of p53, as previous work has shown that mice engineered with hyperactive p53 alleles display show stem cell depletion and premature aging phenotype themselves [38].”
MethodRetractedGenetic Pathways of Aging and Their Relevance in the Dog as a Natural Model of Human Aging
Sándor, S., & Kubinyi, E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00948 · Cited by 72
“Actually, certain hyperactive variants of p53 were shown to reduce lifespan in mice, although with simultaneously prompting increased cancer resistance (Tyner et al., 2002; Dumble et al., 2007).”
BackgroundApolipoprotein E, an important player in longevity and age-related diseases
Ang, L. S., Cruz, R. P., Hendel, A., & Granville, D. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.03.010 · Cited by 76
“As one might expect, a gain-offunction mutation in the p53-encoding gene, Trp53, also yielded an accelerated aging mouse model (Tyner et al., 2002). p53 is a tumour suppressor protein that regulates cell response to DNA damage by promoting either cell senescence or apoptosis (Levine, 1997), and its…”
Cancer: A disease at the crossroads of trade‐offs
Jacqueline, C. M., Biro, P. A., Beckmann, C., Møller, A. P., Renaud, F., Sorci, G., Tasiemski, A., Újvári, B., & Thomas, F. (2016) · Evolutionary Applications · doi:10.1111/eva.12444 · Cited by 79
“For instance, mice carrying a p53 mutation (with a phenotypic effect analogous to the upregulation of the gene) have a lower risk of cancer development, but their life span is reduced and accompanied by early tissue atrophy (Donehower, 2002; Tyner et al., 2002).”
BackgroundGan, D., Xu, X., Chen, D., Feng, P., & Xu, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.915170 · Cited by 65
“Studies have found that TP53 plays a role in regulating tissue aging [51], while p53 induces cell cycle arrest during aging [52], and the activation of autophagy can restore degenerative properties of aged BMMSCs via regulating p53 expression [53].”
BackgroundThe p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior
Liu, Y., Elf, S. E., Asai, T., Miyata, Y., Liu, Y., Sashida, G., Huang, G., Di Giandomenico, S., Koff, A., & Nimer, S. D. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9627 · Cited by 65
“p53 has also been implicated in the aging process.(53,54) p53 hypermorphic (p53/m) mice, that have higher p53 activity than wild-type mice, display premature aging,(53) and aged p53/m mice have fewer HSCs than their p53 and p53 counterparts, with decreased HSC self-renewal capability in transplantation assays.”
BackgroundInflammatory and age-related pathologies in mice with ectopic expression of human PARP-1
Mangerich, A., Herbach, N., Hanf, B., Fischbach, A., Popp, O., Moreno‐Villanueva, M., Bruns†, O. T., & Bürkle, A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.005 · Cited by 67
“Hair regrowth analysis was performed as described previously (Harrison and Archer, 1988; Tyner et al., 2002).”
BackgroundMethodMCH−/− Mice Are Resistant to Aging-Associated Increases in Body Weight and Insulin Resistance
Jeon, J. Y., Bradley, R. L., Kokkotou, E. G., Marino, F. E., Wang, X., Pissios, P., & Maratos-Flier, E. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0203 · Cited by 65
Genetics vs. entropy: Longevity factors suppress the NF-κB-driven entropic aging process
Salminen, A., & Kaarniranta, K. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.11.001 · Cited by 79
“Tyner et al. (2002) generated a p53 mutant mouse which overexpressed a truncated p53 protein.”
BackgroundChronic antigenic load and apoptosis in immunosenescence
Ginaldi, L., Martinis, M. D., Monti, D., & Franceschi, C. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.11.005 · Cited by 69
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.